Skip to main content
Article
Abstract CT053: Intratumoral coxsackievirus A21 increases immune-cell infiltrates and upregulates immune-checkpoint molecules in the tumor microenvironment of advanced melanoma patients: phase II CALM extension study
Cancer Research (2016)
  • Robert Andtbacka, Huntsman Cancer Institute
  • Brendan Curti, Providence Cancer Center, Portland, OR;
  • Sigrun Hallmeyer, Oncology Specialists, Chicago, IL;
  • Zipei Peng, Earle A Chiles Research Institute Providence Cancer Center, Portland, OR;
  • Christopher Paustian, Viralytics Limited, New Lambton, Australia;
  • Carlo Bifulco, Earle A Chiles Research Institute Providence Cancer Center, Portland, OR;
  • Bernard Fox, Earle A Chiles Research Institute Providence Cancer Center, Portland, OR;
  • Mark Grose, Viralytics Limited, Sydney, Australia.
  • Darren R. Shafren, Viralytics Limited, New Lambton, Australia;
Publication Date
July 15, 2016
DOI
10.1158/1538-7445.AM2016-CT053
Citation Information
Robert Andtbacka, Brendan Curti, Sigrun Hallmeyer, Zipei Peng, et al.. "Abstract CT053: Intratumoral coxsackievirus A21 increases immune-cell infiltrates and upregulates immune-checkpoint molecules in the tumor microenvironment of advanced melanoma patients: phase II CALM extension study" Cancer Research Vol. 76 (2016)
Available at: http://works.bepress.com/carlo-bifulco/89/